相关临床试验
5
0 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
N/A
已完成
4
80.0%
招募中
1
20.0%
暂无批准数据
- A University of São Paulo study of 870 patients found that people with diabetes had significantly lower rates of full recovery seven months after COVID-19 hospitalisation (89.8% vs. 94.3%). - Diabetic patients experienced nearly double the rate of post-discharge falls (21% vs. 11.1%) and higher cardiovascular complications including heart attack and angina. - Hospital stays were longer for patients with diabetes (16 days vs. 13 days), contributing to muscle loss and delayed return to daily autonomy. - The study also found 7.3% of previously non-diabetic participants developed diabetes after COVID-19 infection, warranting further investigation.
- A randomized clinical trial of 80 women found that daily 2,000 IU vitamin D supplementation increased complete cancer remission rates to 43% compared to 24% in the placebo group during neoadjuvant chemotherapy. - The study demonstrated a 79% relative increase in full response rates, with most participants initially having vitamin D deficiency below 20 ng/mL at baseline. - Researchers emphasize the need for larger studies to confirm these findings, noting that vitamin D represents an accessible and inexpensive potential adjuvant to standard cancer treatment. - The results align with emerging evidence suggesting vitamin D may function as a "chemosensitizer" that enhances the effectiveness of cancer-fighting drugs at the cellular level.
